- SEK18.83bn
- SEK20.75bn
- €374.70m
- 64
- 13
- 89
- 57
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 26.37 | ||
| PEG Ratio (f) | 0.86 | ||
| EPS Growth (f) | 44.22% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.45 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 39.06 | ||
| Price to Sales | 4.58 | ||
| EV to EBITDA | 22.66 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 4.92% | ||
| Return on Equity | 3.02% | ||
| Operating Margin | 13.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 71.23 | 173.35 | 281.31 | 331.73 | 374.7 | 438.45 | 486.46 | 51.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | -63.78 | -86.59 | +526.06 | +47.65 | +61.4 | +21.37 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- January 2nd, 2020
- Public Since
- June 18th, 2021
- No. of Shareholders
- 2,704
- No. of Employees
- 1,200
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange Stockholm- Shares in Issue
- 523,891,072
- Address
- Riddargatan 19, STOCKHOLM, 114 57
- Web
- https://vimian.com/
- Phone
- Contact
- Maria Tullberg
- Auditors
- Grant Thornton Sweden AB
Upcoming Events for VIMIAN
Q1 2025 Vimian Group AB Earnings Call
Vimian Group AB Annual Shareholders Meeting
Half Year 2025 Vimian Group AB Earnings Release
Q3 2025 Vimian Group AB Earnings Release
Similar to VIMIAN
Biogaia AB
OMX Nordic Exchange Stockholm
BoneSupport Holding AB
OMX Nordic Exchange Stockholm
Camurus AB
OMX Nordic Exchange Stockholm
Cinclus Pharma Holding publ AB
OMX Nordic Exchange Stockholm
Corline Biomedical AB
OMX Nordic Exchange Stockholm
FAQ
What is the Vimian AB share price?
As of Today at 23:58 UTC, shares in Vimian AB are trading at SEK35.94. This share price information is delayed by 15 minutes.
How has the Vimian AB share price performed this year?
Shares in Vimian AB last closed at SEK35.94 and the price had moved by +25.01% over the past 365 days. In terms of relative price strength the Vimian AB share price has outperformed the FTSE Global All Cap Index by +21.88% over the past year.
What are the analyst and broker recommendations for Vimian AB?
The overall consensus recommendation for Vimian AB is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Vimian AB dividend yield?
Vimian AB does not currently pay a dividend.
Does Vimian AB pay a dividend?
Vimian AB does not currently pay a dividend.
When does Vimian AB next pay dividends?
Vimian AB does not currently pay a dividend.
How do I buy Vimian AB shares?
To buy shares in Vimian AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vimian AB?
As of the previous close price of SEK35.94, shares in Vimian AB had a market capitalisation of SEK18.83bn.
Where are Vimian AB shares listed?
Here are the trading details for Vimian AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: VIMIAN
What kind of share is Vimian AB?
Based on an overall assessment of its quality, value and momentum Vimian AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vimian AB share price forecast for 2025?
The analyst consensus target price for shares in Vimian AB is SEK49.09. That is 36.58% above the last closing price of SEK35.94.
Analysts covering Vimian AB currently have a consensus Earnings Per Share (EPS) forecast of €0.12 for the next financial year.
Find out moreWhat is the trend in the Vimian AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vimian AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -20.77%.
As of the last closing price of SEK35.94, shares in Vimian AB were trading -11.67% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vimian AB PE Ratio?
The Vimian AB PE ratio based on its reported earnings over the past 12 months is 26.37. The shares last closed at SEK35.94.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vimian AB?
We do not have data on Vimian AB's directors